Media Releases //

Our Focus is Education & Research of Children's Genetic Diseases of the Brain

MFRF has provided leadership and raised approximately $2.5 million of funding for projects spanning its mission and vision across three pillars: Research of Treatments and Cures, Education and Genetic Screening, and care through Nursing School Educational programs.

MFRF has celebrated wonderful progress in education, genetic testing, and gene therapy patient trials for many affected children and families with fatal genetic diseases of the brain

Kevin Romer Elected President of National Tay-Sachs and Allied Diseases Association

Co-Founder and President of 12-Year-Old South Florida Education and ...
Read More

Kevin Romer Elected Executive V.P. of National Tay-Sachs and Allied Diseases Association

Co-Founder and President of 10-Year-Old South Florida Education and ...
Read More

|| OUR STORIES ||

MFRF has celebrated

wonderful progress in gene therapy patient trials, education, and genetic testing for many affected children and families with fatal genetic diseases of the brain. Still, there is so much more to do, including earlier detection and expanding treatment availability.

Evie

To lose her first child, Evie, ...
Read More

Nicholas

Nicholas was unable to produce critical ...
Read More

Mathew

Mathew was born to Kevin and ...
Read More

Brooke

Brooke was born in 1996 with ...
Read More

William

Back in 2014, the Marquardt family, ...
Read More

Nicole

Nicole Friedland was born a long ...
Read More

Eli

Eli was deeply loved and cared ...
Read More

Cristian

Born a healthy and vibrant boy, ...
Read More

Jordan

On September 17, 2019, after years ...
Read More

Kevin Michael

Kevin Michael Vargas, born to Daniel ...
Read More

Ready to make an impact?

MFRF has celebrated wonderful progress in gene therapy patient trials, education, and genetic testing for many affected children and families with fatal genetic diseases of the brain. Still, there is so much more to do, including earlier detection and expanding treatment availability.

Scroll to Top